Comparative genomic hybridization (CGH) was developed to identify pathogenic DNA copy-number changes (e.g., duplications, deletions) on a genome-wide scale, and to map these changes to genomic ...
Purpose: To address some of the challenges facing the incorporation of array comparative genomic hybridization technology as a clinical tool, including archived tumor tissue, tumor heterogeneity, DNA ...
Figure 1: CGH analyses of genome copy number in murine tissues, tumors and cell lines. We assessed the influence of normal or unaffected cells on our ability to detect single-copy number changes by ...
OXFORD, England--(BUSINESS WIRE)--Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for personalized healthcare based on the EpiSwitch® 3D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback